SUPN News
SUPN
$41.92
+$0.08(+0.19%)
55
Overall
60
Value
45
Tech
60
Quality
Market Cap
$2.44B
Volume
2.82M
52W Range
-- - --
Target Price
$60.50
SUPN news: the latest SUPN headlines, press releases and market updates, newest first.
Latest SUPN News
- Supernus–Indivior Deal Faces Dividend Financing Risk as Citibank Term Loan Remains UncertainTipRanks Auto-Generated Newsdesk · Oct 31, 2026
- Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Supernus Pharmaceuticals (SUPN) and Alignment Healthcare (ALHC)TipRanks Newsroom · Oct 30, 2026
- Analysts Offer Insights on Healthcare Companies: Supernus Pharmaceuticals (SUPN) and Exelixis (EXEL)TipRanks Newsroom · Oct 30, 2026
- Supernus Advances SPN-821 Depression Trial, Adding a New Catalyst for SUPN InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 28, 2026
- Supernus Ends UBS Credit Line Ahead Indivior MergerTipRanks Auto-Generated Newsdesk · Oct 26, 2026
- Supernus Pharmaceuticals (SUPN) Gets a Buy from TD CowenTipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SUPN | $41.92 | +0.2% | 2.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |